which glp 1 agonists have cardiovascular benefit Updated evidence on and renal effects of GLP-1 receptor and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology GLP-1 receptor agonists: The cardiovascular

For more information about how BC Guidelines are developed, refer to the GPAC Handbook available at BCGuidelines.ca: GPAC Handbook

Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder

This article provides a summary of the pharmacological effects of GLP1-based medicines for treatment of obesity-associated complications

These metabolites exert pharmacological effects by protecting hepatocytes from damage, regulating hepatic lipid metabolism, improving insulin sensitivity, and resisting oxidative stress, collectively contributing to the mitigation of MASLD

Johny et al., 2019

Period analysis of individual records was performed using the periodogram method (Muromachi, Tokyo, Japan)